White to Lead Lilly Oncology

Posted: Updated:
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has named Anne White president of Lilly Oncology. White will also serve as senior vice president for the parent company and will succeed Sue Mahony, who is retiring. White first came to Lilly in 1991 as an engineering before taking multiple clinical research and drug development positions inside and outside the company. She currently serves as vice president of portfolio management, Chorus and Next Generation Research & Development.

Lilly says White, a University of Michigan graduate, has held pharmaceutical industry positions in oncology, neuroscience, infectious disease drug development and process transformation, as well as founding an oncology drug development startup that partnered with the Moffitt Cancer Center and the National Cancer Institute.

Chief Executive Dave Ricks says "Anne brings a wealth of experience, expertise and leadership to our executive team. She has led and delivered against our Next Generation Development objectives, accelerating medicines to patients and playing a key role in our recent R&D productivity. Her experience leading significant change transformation within the company will be incredibly valuable as we look toward the future."

Her first day will be September 1.

  • Perspectives

    • What Do Customers Really Think of You?

      Ask a business owner how her customers think about the services they receive or the products they use, and you’ll hear comments like "they love us." But when a third party asks those customers the same question, the results can be eye-opening. I recently shared the story about developing a customer profile for a professional services firm that was eager to grow but lacked useful marketing intelligence about the business it was already handling. We helped them...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Scotty's Brewhouse Files For Bankruptcy

      Indianapolis-based Scotty's Brewhouse has filed for Chapter 11 bankruptcy protection. The company says the decision was "driven largely by the challenges of some specific locations and was necessary because of the way the company was structured corporately." As a result of the deal, Scotty's will close four of its restaurants by the end of the year. In a news release provided to Inside INdiana Business...

    • Churubusco Company Acquired

      Cleveland-based Lincoln Electric Holdings Inc. (Nasdaq: LECO) has announced the acquisitions of two companies, one of which is located in Whitley County. Financial terms of the deal for Churubusco-based Pro Systems LLC and Coldwater Machine Company LLC in Ohio are not being disclosed.

    • Indy Airport to Introduce New Airline

      Indianapolis International Airport will today host an event to welcome a new airline. Airport officials say the provider will add more routes to IND's growing roster of options. Earlier this month, the airport reported record-breaking traffic in the third quarter. IND said the more than 2.4 million passengers that passed through the airport in the third quarter of 2018 marked an 8 percent year-to-date increase over last year and the best third quarter in the facility's history.

    • Shelbyville to Debut Giant Sculpture

      Officials in Shelbyville will this evening unveil a new art installation in the city's downtown. The city says the four-story, $150,000 sculpture known as Blue River - Wind, Rain and Water anchors its ongoing commitment to public art.

    • Work Begins on 16 Tech's First Building

      16 Tech developers have officially broken ground on the innovation district's first building, marking the beginning of an ambitious 10-year project. The $30 million Advanced Research and Innovation building is fully-leased and will anchor the 60-acre development. The facility, which will house the Indiana Biosciences Research Institute, Central Indiana Corporate Partnership and Indiana University School of Medicine researchers, is set to be complete in mid-2020.